Marshall Wace’s BioCardia BCDA Stock Holding History

Marshall Wace’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,445	Closed	-$86K	–	3023
2021 Q2	$86K	Sell	1,445 -1,219	-46%	-$74K	﹤0.01%	2546
2021 Q1	$173K	Buy	+2,664	New	+$166K	﹤0.01%	2298

Other funds holding BCDA

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace's BCDA Position: Q3 2021 in Review

Marshall Wace sold out of BioCardia (BCDA) in Q3 2021, closing a stake of 1,445 shares — an estimated $86K sold.

Marshall Wace first reported a position in BCDA in Q1 2021 and held it in 2 quarters. The position peaked at $173K in Q1 2021. 22 funds tracked by Wall St. Rank hold BCDA as of Q3 2021.

Marshall Wace reported no remaining BioCardia position as of Q3 2021 after selling out during the quarter.
Marshall Wace sold 1,445 BioCardia shares in Q3 2021, an estimated $86K.
Marshall Wace first reported a position in BioCardia in Q1 2021 and held it in 2 quarters.
Marshall Wace's BioCardia position peaked at $173K in Q1 2021.
22 funds tracked by Wall St. Rank held BioCardia as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.